Puberty Suppressing Hormones: Children
The question
To ask the Secretary of State for Health and Social Care, whether any NHS regional gender hubs have prescribed puberty blockers to patients under 18 since the publication of the Cass Review.
Answered by Karin Smyth
From 1 April 2024, NHS England adopted a new clinical commissioning policy that prevents the newly established Children and Young People's Gender Services from initiating prescriptions for gonadotrophin releasing hormone analogues for the purpose of puberty suppression.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →